# EIGER BIOPHARMACEUTICALS INC (EIGRQ)

> Institutional ownership reported to the SEC as of Q2 2025, from Form 13F filings. Source: https://holderbook.com/stocks/EIGRQ/

- Reporting holders: 1
- Reported value: $423.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Propel Bio Management, LLC](https://holderbook.com/funds/1969764-propel-bio-management-llc/) | $423.0K | 146,381 | 0.5% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2025 | 1 | $423.0K |
| Q1 2025 | 1 | $423.0K |
| Q4 2024 | 1 | $765.0K |
| Q3 2024 | 1 | $1.2M |
| Q2 2024 | 2 | $1.9M |
| Q1 2024 | 24 | $3.2M |
| Q2 2023 | 2 | $13.7K |
| Q1 2023 | 2 | $30.3K |
| Q4 2022 | 2 | $16.6K |
| Q3 2022 | 2 | $41.0K |
| Q2 2022 | 2 | $23.0K |
| Q1 2022 | 2 | $907.0K |